Enterococcus faecium 70/90 is a microaerophile, Gram-positive, coccus-shaped bacterium that has multiple antibiotic resistances and was isolated from human faeces, rectal swab.
antibiotic resistance Gram-positive coccus-shaped microaerophile Bacteria| @ref 20215 |
|
Last LPSN update
2026-02-09 11:18:56 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Lactobacillales |
| Family Enterococcaceae |
| Genus Enterococcus |
| Species Enterococcus faecium |
| Full scientific name Enterococcus faecium (Orla-Jensen 1919) Schleifer and Kilpper-Bälz 1984 |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 5098 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 5098 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water | ||
| 36873 | MEDIUM 29- Brain heart agar | Distilled water make up to (1000.000 ml);Brain heart infusion agar (52.000 g) | |||
| 119226 | CIP Medium 29 | Medium recipe at CIP |
| Test 1 | Test 2 | Test 3 | Test 4 | Test 5 | |
|---|---|---|---|---|---|
| @ref | 5098 | 5098 | 5098 | 5098 | 5098 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Müller-Hinton Agar |
| Manual annotation | 1 | 1 | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 12-14 | 14 | 14 | 18 | 20 |
| Ampicillin 10µg (disc) | 12 | 12 | 12 | 8 | 8 |
| Aztreonam 30µg (disc) | 0 | 0 | 0 | 0 | 0 |
| Bacitracin 10Unit | 0 | 0 | 0 | 0 | n.d. |
| Cefalotin 30µg (disc) | 0 | 0 | 0 | 0 | n.d. |
| Cefazolin 30µg (disc) | 0 | 0 | 0 | 0 | n.d. |
| Cefiderocol 30µg (disc) | n.d. | n.d. | n.d. | n.d. | 0 |
| Cefotaxime 30µg (disc) | 0 | 0 | 0 | 0 | 0 |
| Ceftazidime 10µg (disc) | n.d. | n.d. | n.d. | n.d. | 0 |
| Ceftriaxone 30µg (disc) | 0 | 0 | 0 | 0 | 0 |
| Chloramphenicol 30µg (disc) | 24 | 22 | 22 | 24 | 28 |
| Ciprofloxacin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | 24-26 |
| Clindamycin 10µg (disc) | 0 | 0 | 0 | 0 | 0 |
| Colistin 10µg (disc) | 0 | 0 | 0 | 0 | n.d. |
| Colistin sulphate 10µg (disc) | n.d. | n.d. | n.d. | n.d. | 0 |
| Doxycycline 30µg (disc) | 18 | 16 | 16 | 18 | n.d. |
| Erythromycin 15µg (disc) | 0 | 0 | 0 | 0 | 0 |
| Fosfomycin 50µg (disc) | 20 | 20 | 20 | 18 | 20 |
| Gentamicin 30µg (disc) | n.d. | n.d. | n.d. | n.d. | 20 |
| Gentamycin 10µg (disc) | n.d. | ||||
| Imipenem 10µg (disc) | 6 | 10 | 10 | 0 | 0 |
| Kanamycin 30µg (disc) | 10 | 12 | 12 | 12-14 | 14 |
| Levofloxacin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | 26 |
| Lincomycin 15µg (disc) | 0 | 0 | 0 | 0 | n.d. |
| Linezolid 10µg (disc) | 30 | 28 | 28 | 28 | 32 |
| Meropenem 10µg (disc) | n.d. | n.d. | n.d. | n.d. | 0 |
| Mezlocillin 30µg (disc) | 10 | 10 | 10 | 8 | n.d. |
| Moxifloxacin 5µg (disc) | 26 | 24 | 24 | 24-26 | 30 |
| Neomycin 30µg (disc) | 12-14 | 14 | 14 | 18 | n.d. |
| Nitrofurantoin 100µg (disc) | 12 | 10 | 10 | 10 | 10 |
| Norfloxacin 10µg (disc) | 20 | 20 | 20 | 22-24 | n.d. |
| Nystatin 100Unit | 0 | 0 | 0 | 0 | n.d. |
| Ofloxacin 5µg (disc) | 18 | 18 | 18 | 20 | 20 |
| Oxacillin 5µg (disc) | 0 | 0 | 0 | 0 | 0 |
| Penicillin G 6µg (disc) | 0 | 0 | 0 | 0 | 0 |
| Pipemidic acid 20µg (disc) | 0 | 0 | 0 | 0 | n.d. |
| Piperacillin/Tazobactam 40µg (disc) | 6-8 | 6 | 6 | 0 | n.d. |
| Piperacillin/Tazobactam 110µg (disc) | n.d. | n.d. | n.d. | n.d. | 0 |
| Polymyxin B 300Unit | 0 | 0 | 0 | 6 | 0 |
| Quinupristin/Dalfopristin 15µg (disc) | 18 | 18 | 18 | 18-20 | 20 |
| Rifampicin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | 34 |
| Teicoplanin 30µg (disc) | 6-8 | 0 | 0 | 0 | 6 |
| Tetracycline 30µg (disc) | 10 | 0 | 0 | 10 | 10-12 |
| Ticarcillin 75µg (disc) | 0 | 0 | 0 | 0 | 0 |
| Tigecycline 15µg (disc) | n.d. | n.d. | n.d. | n.d. | 28-30 |
| Trimethoprim-sulfamethoxazole (1:19) 10µg (disc) | n.d. | n.d. | n.d. | n.d. | 36 |
| Vancomycin 30µg (disc) | 0 | 0 | 0 | 0 | 0 |
| 5098 | ObservationVancomycin resistant |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68381 | 40585 ChEBI | alpha-cyclodextrin | + | builds acid from | from API rID32STR |
| 68381 | 29016 ChEBI | arginine | + | hydrolysis | from API rID32STR |
| 68381 | 18333 ChEBI | D-arabitol | - | builds acid from | from API rID32STR |
| 68381 | 16899 ChEBI | D-mannitol | + | builds acid from | from API rID32STR |
| 68381 | 16988 ChEBI | D-ribose | + | builds acid from | from API rID32STR |
| 68381 | 16443 ChEBI | D-tagatose | - | builds acid from | from API rID32STR |
| 68381 | 28087 ChEBI | glycogen | - | builds acid from | from API rID32STR |
| 68381 | 30849 ChEBI | L-arabinose | + | builds acid from | from API rID32STR |
| 68381 | 17716 ChEBI | lactose | + | builds acid from | from API rID32STR |
| 68381 | 17306 ChEBI | maltose | + | builds acid from | from API rID32STR |
| 68381 | 6731 ChEBI | melezitose | - | builds acid from | from API rID32STR |
| 68381 | 320055 ChEBI | methyl beta-D-glucopyranoside | + | builds acid from | from API rID32STR |
| 119226 | 17632 ChEBI | nitrate | - | reduction | |
| 119226 | 16301 ChEBI | nitrite | - | reduction | |
| 68381 | 27941 ChEBI | pullulan | - | builds acid from | from API rID32STR |
| 68381 | 16634 ChEBI | raffinose | - | builds acid from | from API rID32STR |
| 68381 | 30911 ChEBI | sorbitol | - | builds acid from | from API rID32STR |
| 68381 | 17992 ChEBI | sucrose | - | builds acid from | from API rID32STR |
| 68381 | 27082 ChEBI | trehalose | + | builds acid from | from API rID32STR |
| 68381 | 16199 ChEBI | urea | - | hydrolysis | from API rID32STR |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 5098 | 161680 | Aztreonam | 30 µg (disc) | from Antibiotic test | |
| 5098 | 28669 | Bacitracin | 10 Unit | from Antibiotic test | |
| 5098 | 124991 | Cefalotin | 30 µg (disc) | from Antibiotic test | |
| 5098 | 474053 | Cefazolin | 30 µg (disc) | from Antibiotic test | |
| 5098 | 140376 | Cefiderocol | 30 µg (disc) | from Antibiotic test | |
| 5098 | 204928 | Cefotaxime | 30 µg (disc) | from Antibiotic test | |
| 5098 | 3508 | Ceftazidime | 10 µg (disc) | from Antibiotic test | |
| 5098 | 29007 | Ceftriaxone | 30 µg (disc) | from Antibiotic test | |
| 5098 | 3745 | Clindamycin | 10 µg (disc) | from Antibiotic test | |
| 5098 | 37943 | Colistin | 10 µg (disc) | from Antibiotic test | |
| 5098 | 37943 | Colistin sulphate | 10 µg (disc) | from Antibiotic test | |
| 5098 | 48923 | Erythromycin | 15 µg (disc) | from Antibiotic test | |
| 5098 | 6472 | Lincomycin | 15 µg (disc) | from Antibiotic test | |
| 5098 | 43968 | Meropenem | 10 µg (disc) | from Antibiotic test | |
| 5098 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 5098 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 5098 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | |
| 5098 | 75250 | Pipemidic acid | 20 µg (disc) | from Antibiotic test | |
| 5098 | Piperacillin/Tazobactam | 110 µg (disc) | from Antibiotic test | ||
| 5098 | 9587 | Ticarcillin | 75 µg (disc) | from Antibiotic test | |
| 5098 | 28001 | Vancomycin | 30 µg (disc) | from Antibiotic test |
| @ref | Chebi-ID | Metabolite | Voges-proskauer-test | |
|---|---|---|---|---|
| 68381 | 15688 ChEBI | acetoin | + | from API rID32STR |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 68381 | Alanyl-Phenylalanyl-Proline arylamidase | - | from API rID32STR | |
| 68382 | alkaline phosphatase | - | 3.1.3.1 | from API zym |
| 68381 | alkaline phosphatase | - | 3.1.3.1 | from API rID32STR |
| 68382 | alpha-chymotrypsin | + | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68381 | arginine dihydrolase | + | 3.5.3.6 | from API rID32STR |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 68381 | beta-galactosidase | + | 3.2.1.23 | from API rID32STR |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68381 | beta-glucosidase | + | 3.2.1.21 | from API rID32STR |
| 68382 | beta-glucuronidase | + | 3.2.1.31 | from API zym |
| 68381 | beta-glucuronidase | - | 3.2.1.31 | from API rID32STR |
| 5098 | catalase | - | 1.11.1.6 | |
| 119226 | catalase | - | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 5098 | cytochrome-c oxidase | - | 1.9.3.1 | |
| 68382 | esterase (C 4) | - | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 68381 | glycyl tryptophan arylamidase | + | from API rID32STR | |
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | - | from API zym | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68381 | N-acetyl-beta-glucosaminidase | + | 3.2.1.52 | from API rID32STR |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 119226 | oxidase | - | ||
| 68381 | pyrrolidonyl arylamidase | + | 3.4.19.3 | from API rID32STR |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 119226 | urease | - | 3.5.1.5 | |
| 68381 | urease | - | 3.5.1.5 | from API rID32STR |
| 68382 | valine arylamidase | - | from API zym |
| @ref | ADH (Arg) | beta GLU | beta GAR | beta GUR | alpha GAL | PAL | RIB | MAN | SOR | LAC | TRE | RAF | SAC | LARA | DARL | Acid from alpha-cyclodextrinCDEX | Acetoin production (Voges Proskauer test)VP | Alanyl-Phenylalanyl-Proline arylamidaseAPPA | beta GAL | Pyrrolidonyl arylamidasePyrA | N-Acetyl-glucosaminidasebeta NAG | Glycyl-tryptophan arylamidaseGTA | HIP | GLYG | PUL | MAL | MEL | MLZ | Acidification of methyl beta-D-glucopyranosideMbeta DG | TAG | beta MAN | URE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5098 | + | + | - | - | - | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | + | + | + | - | - | + | - | - | + | - | - | - | |
| 5098 | + | + | + | - | - | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | + | + | + | - | - | + | - | - | + | - | + | - | |
| 5098 | + | + | - | - | +/- | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | + | + | - | - | - | + | + | - | + | - | - | - | |
| 5098 | + | + | + | - | - | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | + | + | - | - | - | + | - | - | + | - | + | - | |
| 5098 | + | + | + | - | - | - | + | + | - | + | + | - | - | + | - | + | + | - | + | + | + | + | +/- | - | - | + | - | - | + | - | + | - |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| A Study of Bioactivities and Composition of a Cocktail of Supernatants Derived from Lactic Acid Bacteria for Potential Food Applications. | Huang X, Nzekoue FK, Wang J, Attili AR, Coman MM, Verdenelli MC, Fiorini D, Rossi G, Marchini C, Miceli C, Silvi S. | Probiotics Antimicrob Proteins | 10.1007/s12602-024-10442-w | 2025 | | |
| Peppermint Essential Oil-Doped Hydroxyapatite Nanoparticles with Antimicrobial Properties. | Badea ML, Iconaru SL, Groza A, Chifiriuc MC, Beuran M, Predoi D. | Molecules | 10.3390/molecules24112169 | 2019 | | |
| Activity of Fosfomycin- and Daptomycin-Containing Bone Cement on Selected Bacterial Species Being Associated with Orthopedic Infections. | Eick S, Hofpeter K, Sculean A, Ender C, Klimas S, Vogt S, Nietzsche S. | Biomed Res Int | 10.1155/2017/2318174 | 2017 | | |
| Enhancing the antimicrobial activity of silver nanoparticles against ESKAPE bacteria and emerging fungal pathogens by using tea extracts. | Raza S, Wdowiak M, Grotek M, Adamkiewicz W, Nikiforow K, Mente P, Paczesny J. | Nanoscale Adv | 10.1039/d3na00220a | 2023 | | |
| Pharmacological and behavioral investigation of putative self-medicative plants in Budongo chimpanzee diets. | Freymann E, Carvalho S, Garbe LA, Dwi Ghazhelia D, Hobaiter C, Huffman MA, Muhumuza G, Schulz L, Sempebwa D, Wald F, Yikii ER, Zuberbuhler K, Schultz F. | PLoS One | 10.1371/journal.pone.0305219 | 2024 | | |
| The biology and toxinology of blunt-nosed vipers | Avella I, Damm M, Di Nicola M, Dresler J, Igci N, Karis M, Kazemi S, Kreuels B, Paolino G, Sarigiannis Y, Vilcinskas A, Wuster W, Luddecke T. | NPJ Biodivers | 2025 | | ||
| Lactic Acid Bacteria as Antimicrobial Agents: Food Safety and Microbial Food Spoilage Prevention. | Ibrahim SA, Ayivi RD, Zimmerman T, Siddiqui SA, Altemimi AB, Fidan H, Esatbeyoglu T, Bakhshayesh RV. | Foods | 10.3390/foods10123131 | 2021 | | |
| X-ray Crystal Structure, Geometric Isomerism, and Antimicrobial Activity of New Copper(II) Carboxylate Complexes with Imidazole Derivatives. | Vlaicu ID, Borodi G, Scaeteanu GV, Chifiriuc MC, Marutescu L, Popa M, Stefan M, Mercioniu IF, Maurer M, Daniliuc CG, Olar R, Badea M. | Molecules | 10.3390/molecules23123253 | 2018 | | |
| Current Knowledge on Biomaterials for Orthopedic Applications Modified to Reduce Bacterial Adhesive Ability. | Allizond V, Comini S, Cuffini AM, Banche G. | Antibiotics (Basel) | 10.3390/antibiotics11040529 | 2022 | | |
| Medicinal Uses, Phytochemistry, Pharmacology, and Toxicology of Mentha spicata. | El Menyiy N, Mrabti HN, El Omari N, Bakili AE, Bakrim S, Mekkaoui M, Balahbib A, Amiri-Ardekani E, Ullah R, Alqahtani AS, Shahat AA, Bouyahya A. | Evid Based Complement Alternat Med | 10.1155/2022/7990508 | 2022 | | |
| Validation of a novel real-time PCR for detecting Rasamsonia argillacea species complex in respiratory secretions from cystic fibrosis patients. | Steinmann J, Giraud S, Schmidt D, Sedlacek L, Hamprecht A, Houbraken J, Meis JF, Bouchara JP, Buer J, Rath PM. | New Microbes New Infect | 10.1002/nmi2.44 | 2014 | | |
| Metabolism | Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis. | Essig A, Hofmann D, Munch D, Gayathri S, Kunzler M, Kallio PT, Sahl HG, Wider G, Schneider T, Aebi M. | J Biol Chem | 10.1074/jbc.m114.599878 | 2014 | |
| Pathogenicity | Sintered and 3D-Printed Bulks of MgB2-Based Materials with Antimicrobial Properties. | Badica P, Batalu ND, Chifiriuc MC, Burdusel M, Grigoroscuta MA, Aldica GV, Pasuk I, Kuncser A, Popa M, Agostino A, Operti L, Padhi SK, Bonino V, Truccato M | Molecules | 10.3390/molecules26196045 | 2021 | |
| Effect of Ottoman Viper (Montivipera xanthina (Gray, 1849)) Venom on Various Cancer Cells and on Microorganisms. | Yalcin HT, Ozen MO, Gocmen B, Nalbantsoy A | Cytotechnology | 10.1007/s10616-013-9540-z | 2013 | | |
| Pathogenicity | Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium. | Caron F, Pestel M, Kitzis MD, Lemeland JF, Humbert G, Gutmann L | J Infect Dis | 10.1093/infdis/171.1.106 | 1995 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive5299.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License